Profiling miRNA Biomarkers in Cells, FFPE, and Clinical Biofluid Samples
|SPEAKER:||Kirsteen MaClean, Senior Application Scientist, NanoString Technologies|
Jun 01, 2016
nCounter® Technology: a growing suite of applications.
Recent studies have shown that changes in miRNA can be correlated with gene expression changes in development, differentiation, signal transduction, infection, aging and disease.
View this webinar and learn about NanoString's nCounter miRNA assay, applications such as biomarker discovery and signature development, data from various sample types, and capability of performing one assay for both miRNA and mRNA from the same sample.